All Type of News
Celltrion received approval of Phase 3 clinical trial pla of 'CT-P10'
On June 29, Ministry of Food and Drug Safety approved Phase 3 clinical trial pla of 'CT-P10' from Celltrion. 'CT-P10' is a biosimilar product of MabThera (ingredient name: rituximab) which is for the treatment of rheu...
It is expected that top pharmaceutical companies will record an average of 16% increase in sales
On June 26, according to the pharmaceutical industry report of KTB Investment & Securities Co., it was expected that 5 companies including Yuhan Corporation, Green Cross, Hanmi Pharmaceutical, Daewoong, and LG Life Sc...
It was known that mid-sized listed pharmaceutical company with the scale of about 100 billion won is the target of M&A
Recently, there was a rumor that the mid-sized pharmaceutical company A will merge. It was also known that CJ Healthcare which proclaimed independent corporation is specifically promoting mergers and acquisition of a ...
As the patent of Crestor expires, the hyperlipidemia treatment market is expected to be more competitive
As the patent of Crestor expires, the hyperlipidemia treatment market is expected to be more competitive.
It was identified that prescription amount of hyperlipidemia treatment in May is similar to the previous year....
Wound Dressing market with the scale of 80 billion won is becoming larger and competition stronger
Wound Dressing market with the scale of 80 billion won is becoming larger and competition stronger.
Recently, the sales company of market leader product 'Medifoam' was changed from Ildong Pharmaceutical to Mundipharm...
Domestic small business 'TECH WORLD' succeeded in developing the technology with the production speed of soft capsules three times faster
Soft capsule is commonly used as formulation of medicines and health supplements. Domestic small business 'TECH WORLD' succeeded in developing the technology in which the production speed of soft capsules become three...
There is an increasing call for blocking illegal sales with taking advantage of CSO
With the implementation of 'Illegal kickback Two-strike out system' ahead in July, there is an increasing call for blocking potential of illegal sales with taking advantage of CSO.
On June 25, Korea Pharmaceutical Ma...
Ahngook Pharmaceutical, CHA Biotech and Alvogen participated in the main bidding of DreamPharma acquisition
It was identified that Ahngook Pharmaceutical, CHA Biotech and Alvogen participated in the main bidding of DreamPharma acquisition which was closed on June 25.
Dream Pharma is a subsidiary of Hanwha Group, of which H...
Price fall of infusion solution in national and public hospitals is being exacerbated
According to the related industry, price fall of infusion solution in national and public hospitals is being exacerbated.
It is difficult for pharmaceutical companies • wholesale companies to make a profit in deliver...
National Health Insurance Service suggested making colonoscopy mandatory
On June 25, National Health Insurance Service held an inbada on regulatory reform for public benefit. National Health Insurance Service insisted that in order to increase low screening rate of colorectal cancer, colon...
